Joel Greenblatt · Magic Formula: high return on capital at a cheap EV/EBIT
Is Arbutus Biopharma Corporation (ABUS) a Joel Greenblatt Stock?
High-quality business at a cheap price, strong Magic Formula fit.
100/100
Fits
3/5 criteria passed
Joel Greenblatt's Criteria, Applied to ABUS
EBIT/EV yield ≥ 10%
key-
ROIC ≥ 25%
key56.7%
EV/EBIT ≤ 12
-
Gross margin ≥ 30%
100.0%
How ABUS Scores on Other Strategies
Live Financial Snapshot
Market cap
$656.02M
P/E (TTM)
5.1x
ROIC (TTM)
56.72%
Gross margin
99.98%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is ABUS's Joel Greenblatt fit score?
ABUS scores 100/100 on our Joel Greenblatt fit engine. High-quality business at a cheap price, strong Magic Formula fit.
Does Joel Greenblatt actually own ABUS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ABUS.
How often is this score updated?
ABUS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends ABUS.
